Article
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
18 Dec 2017
Abstract excerpt
Multidrug resistance (MDR) is a major cause of failure in cancer chemotherapy. P-glycoprotein (P-gp), a promiscuous drug efflux pump, has been extensively studied for its association with MDR due to overexpression in cancer cells. Several P-gp inhibitors or modulators have been investigated in clinical trials in hope of circumventing MDR, with only limited success. Alternative strategies are actively pursued,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
